Clik here to view.
Compass Pathways to participate in upcoming Oppenheimer investor conference
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a...
View ArticleClik here to view.
Mernova Continues Strong Progress in Q1 FY24
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that wholly- owned Canadian subsidiary, Mernova Medicinal Inc. (‘Mernova’) has achieved further operational...
View ArticleClik here to view.
Melodiol Global Health Limited (ASX: ME1) – Trading Halt
DescriptionThe securities of Melodiol Global Health Limited (‘ME1’) will be placed in trading halt at the request of ME1, pending it releasing an announcement. Unless ASX decides otherwise, the...
View ArticleClik here to view.
Capital Raising & Corporate Update
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise it has received firm commitments to raise ~$1.08m (before costs) through the issue of approximately...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end 2023 financial...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial...
View ArticleClik here to view.
FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To...
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today...
View ArticleClik here to view.
Compass Pathways to participate in upcoming TD Cowen investor conference
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in...
View ArticleClik here to view.
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business...
- Highlights: COMP360 phase 3 pivotal program ongoing; COMP005 trial top-line data now expected in fourth quarter 2024, COMP006 remains on track for top-line data in mid-2025 Teri Loxam to assume...
View ArticleClik here to view.
Appendix 4E Preliminary Final Report Year Ended 31 December 2023
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to present its Preliminary Final Year Report. PRELIMINARY FINAL REPORTFor the year ended 31 December 2023, previous...
View ArticleClik here to view.
Goodness Growth Holdings to Release Fourth Quarter and Full Year 2023 Results...
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers,...
View ArticleClik here to view.
Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic...
Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today...
View ArticleClik here to view.
Goodness Growth Holdings Reschedules Fourth Quarter and Full Year 2023...
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers,...
View ArticleClik here to view.
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder...
Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and...
View ArticleClik here to view.
ACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health...
Led by Steven Acevedo and Art Isagholian, ACE Venture Enterprises, Inc., a minority-owned business, plans to acquire Vireo Health of New York to accelerate entry into the New York market – – Ace plans...
View ArticleClik here to view.
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the...
View ArticleClik here to view.
Goodness Growth Holdings Announces Fourth Quarter and Full Year 2023 Results
Company demonstrates improved performance with record revenue and operating income in fiscal year 2023 – – Q4 2023 revenue of $24.2 million excluding discontinued operations increased 34.4%...
View ArticleClik here to view.
CORRECTION - ACE Venture Enterprises, Inc. Announces Planned Acquisition of...
Led by Steven Acevedo and Art Isagholian, ACE Venture Enterprises, Inc., a minority-owned business, plans to acquire Vireo Health of New York to accelerate entry into the New York market – – Ace plans...
View ArticleClik here to view.
Emyria Selected by Reach Wellness to Lead MDMA -Assisted Therapy Research for...
Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) investigating new treatments for mental health and select neurological conditions, is pleased to announce it has entered into a binding research...
View ArticleClik here to view.
Health House Australia and Corporate Update
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Australian subsidiary, Health House Australia, continues to make strong operational...
View ArticleClik here to view.
Psychedelics Outlook Report
@media (max-width: 500px){ table,tr,td{ display: block; } } .form-info, .cplistAu, .checkbox-label{ font-size: 14px !important; color: #343A40; } li { font-size: 14px !important; color: #343A40; }...
View Article